|

Survodutide Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: BI 456906

Pipeline

Phase 3: 2

Top Sponsors

  • Boehringer Ingelheim2

Indications

  • Liver Disease2
  • Metabolic Dysfunction-Associated Steatohepatitis (MASH)1
  • Liver Fibrosis1
  • Metabolic Dysfunction-Associated Steatohepatitis1

Birmingham, Alabama1 trial

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

University of Alabama at Birmingham

Phase 3

Peoria, Arizona1 trial

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

The Institute for Liver Health II DBA Arizona Clinical Trials

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.